Product development - non clinical
Non Clinical studies enables assessment of safety and pharmacokinetics and toxicokinetics of a candidate. We understand that for biosimilars preclinical development program is more comprehensive.
Optimal & Customized Non Clinical Strategy for each product
Strategy Compliant to Regulatory requirements
Execution services for Non Clinical studies (via our partners)
Our Nonclinical package expedites transition to your Clinical program